Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-13-041879
Filing Date
2013-11-12
Accepted
2013-11-12 17:15:22
Documents
14
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 ASTERIAS BIOTHERAPEUTICS, INC 10-Q 9-30-2013 form10q.htm 10-Q 616186
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 1263700
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 218628
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 51671
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 210554
6 EXHIBIT 10.5 ex10_5.htm EX-10.5 220439
7 EXHIBIT 31 ex31.htm EX-31 21222
8 EXHIBIT 32 ex32.htm EX-32 5882
  Complete submission text file 0001140361-13-041879.txt   5511776

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ast-20130930.xml EX-101.INS 390505
10 XBRL TAXONOMY EXTENSION SCHEMA ast-20130930.xsd EX-101.SCH 28400
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ast-20130930_cal.xml EX-101.CAL 26561
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ast-20130930_def.xml EX-101.DEF 128429
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE ast-20130930_lab.xml EX-101.LAB 378317
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ast-20130930_pre.xml EX-101.PRE 224873
Mailing Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 230 CONSTITUTION DRIVE MENLO PARK CA 94025 510-521-3390
Asterias Biotherapeutics, Inc. (Filer) CIK: 0001572552 (see all company filings)

EIN.: 461047971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55046 | Film No.: 131211357
SIC: 2836 Biological Products, (No Diagnostic Substances)